FDA panel says Avastin should not be marketed for breast cancer treatment
Tuesday, July 20, 2010 - 20:49
in Health & Medicine
The recommendation does not affect the drug's marketing for treatment of four other types of cancer. New trials failed to confirm initial studies indicating some benefit for breast cancer patients. A Food and Drug Administration advisory committee Tuesday recommended that the agency withdraw its marketing approval of the blockbuster cancer drug Avastin for treating breast cancer, concluding that new trials showed no apparent...